Biocon Limited header image

Biocon Limited

532523

Equity

ISIN INE376G01013 / Valor 1806852

Bombay Stock Exchange Ltd. (Mumbai) (2026-05-27)
INR 431.40-1.04%

Biocon Limited
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Biocon Limited is India's largest biopharmaceutical company, founded in 1978 by Kiran Mazumdar-Shaw and headquartered at Biocon Special Economic Zone, Bommasandra Industrial Area, Bengaluru. The company manufactures generic APIs, biosimilar insulins, biosimilar antibodies (Biocon Biologics subsidiary) and novel biologics, and provides contract research and manufacturing (CRO/CRAMS) services through Syngene International. Key biosimilar products include insulin glargine (Lantus), trastuzumab (Herceptin), bevacizumab and adalimumab. In FY25, significant launches included Lenalidomide and Dasatinib in the US and biosimilar Liraglutide (gLP-1) in the UK. In June 2025, Biocon raised ₹4,500 crore via QIP. Revenue ₹16,470 crore FY25. Listed on both BSE and NSE (BIOCON).

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

28.6%1Y
80.2%3Y
13.1%5Y

Performance

26.6%1Y
32.5%3Y
31.6%5Y

Volatility

Market cap

6000 M

Market cap (USD)

Daily traded volume (Shares)

948,783

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Galapagos NV
Galapagos NV Galapagos NV Valor: 3542077
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.13%USD 28.32
Vitrolife AB
Vitrolife AB Vitrolife AB Valor: 41707777
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%SEK 100.90
Schrodinger Inc
Schrodinger Inc Schrodinger Inc Valor: 51947209
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.95%USD 14.16
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.52%USD 234.66
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.52%CHF 77.90
medmix Ltd
medmix Ltd medmix Ltd Valor: 112967710
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.22%CHF 9.04
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 57.40
Evolva Holding LTD
Evolva Holding LTD Evolva Holding LTD Valor: 126205578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.40%CHF 1.37
UCB SA
UCB SA UCB SA Valor: 986410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.04%EUR 244.20
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.22%USD 515.96